Portfolio 5
| Date | Name | Website | Total Raised | Location |
| - | Asterand, ... | asterand.c... | - | - |
| - | ProNAi The... | pronai.com | $72M | Canada, Br... |
| - | Kereos | kereos.com | $5.6M | - |
| - | Svelte Med... | sveltemedi... | $43M | - |
| - | ZyStor | zystor.com | - | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 22.07.2014 | MoneyTree Reports $121M in MI Venture Deals Last Quarter | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Venture Capital investors had a ve... | xconomy.co... |
| 22.04.2014 | ProNAi Therapeutics Closes on $59.5M to Advance Cancer Drug | Share Share on Facebook Share on Twitter LinkedIn Email Reprints ProNAi Therapeutics, a Plymouth, M... | xconomy.co... |
| 21.04.2014 | ProNAi raises $60 million to advance treatment to combat lym... | Among the applications for its PNT2258 treatment are diffuse large B-cell lymphoma, Richter’s transf... | medcitynew... |
| 18.06.2010 | CytoPherx raises $5M to develop dialysis filters | The lead investor in the round was Diamond Capital Management of Midland, Michigan, with participati... | medcitynew... |
| 18.06.2010 | CytoPherx drums up $11.7 million for dialysis development | By Brandon Glenn CytoPherx Inc. raised $11.7 million for the development of a device that filters t... | massdevice... |
| - | CytoPherx raises $5M to develop dialysis filters | CytoPherx Inc. has raised $5 million of an anticipated $7.5 million Series B round to develop a devi... | medcitynew... |
| - | ProNAi raises $60 million to advance treatment to combat lym... | Cancer drug developer ProNAi Therapeutics, which developed a nucleic acid-based DNA-interference tec... | medcitynew... |